Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 514,542 | 575,140 | 697,526 | 790,675 | 759,598 |
| Marketable Securities | 1,176,115 | 944,381 | 629,218 | 437,870 | 448,146 |
| Receivables | 584,603 | 581,052 | 666,960 | 687,609 | 605,329 |
| Inventories | 326,843 | 310,934 | 308,254 | 295,260 | 289,066 |
| Other current assets | 373,324 | 425,781 | 386,665 | 416,901 | 438,281 |
| TOTAL | $2,975,427 | $2,837,288 | $2,688,623 | $2,628,315 | $2,540,420 |
| Non-Current Assets | |||||
| PPE Net | 1,571,387 | 1,572,259 | 1,712,869 | 1,673,502 | 1,641,634 |
| Investments And Advances | 1,748,285 | 1,587,229 | 1,395,306 | 1,113,549 | 991,299 |
| Intangibles | 2,754,505 | 2,805,428 | 2,825,181 | 2,878,158 | 2,919,140 |
| Other Non-Current Assets | 0 | 0 | -1 | 0 | 0 |
| TOTAL | $6,074,177 | $5,964,916 | $5,933,355 | $5,665,209 | $5,552,073 |
| Total Assets | $9,049,604 | $8,802,204 | $8,621,979 | $8,293,524 | $8,092,493 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 186,448 | 159,197 | 170,746 | 159,136 | 162,529 |
| Accrued Expenses | 677,210 | 674,743 | 641,273 | 591,448 | 665,923 |
| TOTAL | $912,889 | $885,346 | $954,330 | $978,846 | $1,050,122 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,060,808 | 1,060,639 | 1,062,986 | 1,065,613 | 1,066,379 |
| Other Non-Current Liabilities | 400,304 | 382,614 | 335,670 | 341,826 | 294,125 |
| TOTAL | $1,709,728 | $1,683,264 | $1,611,455 | $1,640,378 | $1,592,928 |
| Total Liabilities | $2,622,617 | $2,568,610 | $2,565,785 | $2,619,224 | $2,643,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 238,725 | 242,917 | 242,546 | 241,632 | 240,912 |
| Common Shares | 128 | 128 | 127 | 125 | 124 |
| Retained earnings | 3,106,761 | 2,806,523 | 2,454,848 | 2,166,813 | 1,872,481 |
| Other shareholders' equity | -24,950 | 12,514 | 105,354 | 68,934 | 31,735 |
| TOTAL | $6,426,987 | $6,233,594 | $6,056,194 | $5,674,300 | $5,449,443 |
| Total Liabilities And Equity | $9,049,604 | $8,802,204 | $8,621,979 | $8,293,524 | $8,092,493 |